TEKMIRA PHARMACEUTICALS CORP's ticker is TKMR and the CUSIP is 87911B209. A total of 48 filers reported holding TEKMIRA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $9,201,000 | -30.2% | 775,803 | +2.8% | 0.01% | -26.7% |
| Q1 2015 | $13,177,000 | +19.5% | 754,723 | +3.7% | 0.02% | +25.0% |
| Q4 2014 | $11,028,000 | -36.5% | 727,895 | -11.4% | 0.01% | -40.0% |
| Q3 2014 | $17,363,000 | +61.2% | 821,320 | -0.4% | 0.02% | +66.7% |
| Q2 2014 | $10,769,000 | -37.6% | 824,596 | +2.7% | 0.01% | -45.5% |
| Q1 2014 | $17,252,000 | +188.8% | 802,812 | +7.1% | 0.02% | +175.0% |
| Q4 2013 | $5,974,000 | +7.6% | 749,599 | -6.2% | 0.01% | -11.1% |
| Q3 2013 | $5,552,000 | +49.6% | 798,869 | +1.1% | 0.01% | +28.6% |
| Q2 2013 | $3,712,000 | – | 789,828 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 16,013,540 | $279,596,000 | 15.57% |
| RA Capital Management | 2,714,800 | $47,400,000 | 4.71% |
| Alpha Wave Global, LP | 2,221,000 | $38,779,000 | 1.90% |
| Redmile Group, LLC | 700,000 | $12,222,000 | 1.10% |
| HealthCor Management, L.P. | 718,800 | $12,550,000 | 0.60% |
| Monashee Investment Management LLC | 55,000 | $960,000 | 0.60% |
| SPHERA FUNDS MANAGEMENT LTD. | 298,486 | $5,212,000 | 0.54% |
| Telemetry Investments, L.L.C. | 48,000 | $838,000 | 0.46% |
| Anson Funds Management LP | 25,000 | $437,000 | 0.39% |
| Blue Ridge Capital, L.L.C. | 1,700,000 | $29,682,000 | 0.34% |